Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.87 USD | +2.80% | +3.25% | -40.27% |
Jun. 03 | Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing | MT |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Other languages